Calculating LDL in Nonfasting State
For most clinical scenarios, nonfasting lipid profiles are acceptable for LDL calculation, and the standard Friedewald formula can be used when triglycerides are <400 mg/dL. 1
Standard Methods for LDL Calculation
Friedewald Formula (Standard Method)
- LDL-C = Total Cholesterol - HDL-C - (Triglycerides/5)
- This is valid when triglycerides are <400 mg/dL (<4.5 mmol/L)
- In nonfasting samples, this remains accurate for most patients 1, 2
When to Use Direct LDL-C Measurement
Direct measurement of LDL-C (or modified LDL-C estimation) is recommended when:
- Triglycerides ≥400 mg/dL (≥4.5 mmol/L) 1
- LDL-C levels are very low (<70 mg/dL or <1.8 mmol/L) 1, 3
- Patient has Type III dyslipidemia (dysbetalipoproteinemia) 4
Alternative Calculation Methods
Martin-Hopkins Method
- Uses a 180-cell stratification of TG/non-HDL-C to determine the TG:VLDL-C ratio
- More accurate for low LDL-C levels (<70 mg/dL) and when triglycerides are between 150-399 mg/dL
- Valid in nonfasting state
- Can be used with triglycerides up to 4.5 mmol/L 3, 5
Sampson-NIH2 Equation
- Uses beta-quantification and multiple least squares regression
- Can be used with triglycerides up to 9 mmol/L
- Particularly useful in hypertriglyceridemia 5
Impact of Nonfasting State on Lipid Values
Nonfasting lipid profiles show minimal clinically significant differences compared to fasting samples:
- Total Cholesterol: -0.2 mmol/L (8 mg/dL) lower
- LDL Cholesterol: -0.2 mmol/L (8 mg/dL) lower (approximately 10%)
- HDL Cholesterol: -0.1 mmol/L (4 mg/dL) lower
- Triglycerides: +0.3 mmol/L (26 mg/dL) higher (up to 20%) 2
Clinical Algorithm for LDL Calculation in Nonfasting State
For routine assessment in most patients:
- Use nonfasting lipid profile
- Calculate LDL-C using Friedewald formula
If initial nonfasting triglycerides ≥400 mg/dL:
- Repeat lipid profile in fasting state 1
- If still ≥400 mg/dL, use direct LDL-C measurement
If LDL-C is <70 mg/dL:
For patients with suspected familial hyperlipidemia or genetic disorders:
- Use fasting lipid profile for initial evaluation 1
For monitoring lipid-lowering therapy:
- Initial follow-up (4-8 weeks after starting therapy): fasting lipid profile
- Long-term stable therapy: nonfasting lipid profile is acceptable 2
Special Considerations
- When triglycerides are very low (<50 mg/dL) with high cholesterol, Friedewald formula may overestimate LDL-C; direct measurement is preferred 6
- Sample freezing can affect direct LDL-C measurement (15.1% decrease after 30 days of freezing) 4
- Non-HDL cholesterol (Total Cholesterol - HDL Cholesterol) can be used as an alternative marker, especially when triglycerides are elevated 1
Remember that nonfasting lipid testing improves patient compliance, reduces laboratory congestion, and better reflects the body's typical metabolic state, with minimal impact on clinical decision-making for most patients 2.